Related Experiment Videos
Drug delivery to tumors. A problem requiring microscopic resolution
Analytical and Quantitative Cytology and Histology
|June 1, 1986
Summary
Chemotherapy drug delivery varies widely within tumors and metastases. Some areas show low drug uptake, potentially leading to drug-resistant cells and tumor recurrence, highlighting the need for microscopic drug delivery studies.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- Chemotherapy effectiveness relies on drug delivery to cancer cells.
- Adriamycin uptake is crucial for treating primary tumors and metastases.
Purpose of the Study:
- To investigate the variability of Adriamycin uptake in primary tumors, lung metastases, and normal lung tissue in mice.
- To identify factors influencing drug delivery and potential drug resistance within tumors.
Main Methods:
- Assaying Adriamycin uptake in 8 cu mm tissue samples from primary tumors, lung metastases, and normal lung tissue.
- Utilizing three-dimensional reconstruction and automated microscopic image analysis for detailed study.
Main Results:
- Significant variations in Adriamycin uptake were observed between different tumors, between primary tumors and metastases, and among metastases.
- Tumor tissues exhibited greater uptake heterogeneity compared to normal lung tissues.
- Low drug uptake levels in some tumor areas suggest the presence of drug-resistant cells, potentially contributing to tumor recurrence.
Conclusions:
- Adriamycin uptake is highly heterogeneous within tumors, impacting chemotherapy effectiveness.
- Microscopic-level studies and advanced imaging techniques are essential for understanding and improving drug delivery to tumors.